— Know what they know.
Not Investment Advice

IVRO OTC

InVitro International
1W: +0.0% 1M: -14.3% 3M: -29.7% YTD: -39.9% 1Y: +0.0% 3Y: -17.2% 5Y: -60.0%
$0.06
-0.01 (-7.69%)
 
Weekly Expected Move ±10.6%
$0 $0 $0 $0 $0
OTC · Healthcare · Medical - Diagnostics & Research · Tech Score Neutral · Power 47 · $1.3M mcap · 16M float · 0.115% daily turnover · Short 76% of daily vol

Balance Sheet Trends

Total Assets
$2M +2.8% ▲
5Y CAGR: +5.4%
Total Liabilities
$348K -8.7% ▼
5Y CAGR: +10.4%
Shareholders Equity
$2M +5.5% ▲
5Y CAGR: +4.5%
Cash & Investments
$1M -3.8% ▼
5Y CAGR: +1.0%
Total Debt
$287K -15.5% ▼
5Y CAGR: +21.9%
Net Debt
-$378K -389.1% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$522K$1M$357K$417K$665K
Short-Term Investments$785K$0$816K$854K$558K
Cash & ST Investments$1M$1M$1M$1M$1M
Net Receivables$122K$51K$97K$61K$59K
Inventory$140K$158K$163K$184K$183K
Other Current Assets$0$0$0$0$0
Total Current Assets$2M$1M$1M$2M$2M
Property, Plant & Equip.$8K$15K$54K$349K$283K
Goodwill & Intangibles$10K$9K$8K$7K$10K
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$8K$7K$5K$25K$196K
Total Non-Current Assets$27K$30K$67K$381K$489K
Total Assets$2M$2M$2M$2M$2M
— Liabilities —
Accounts Payable$3K$5K$8K$1K$4K
Short-Term Debt$101K$0$0$53K$63K
Deferred Revenue$10K$0$800$0$0
Other Current Liabilities$0$26K$22K$26K$34K
Total Current Liabilities$202K$68K$79K$94K$124K
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$0$287K$224K
Total Liabilities$202K$68K$79K$381K$348K
— Equity —
Common Stock$669K$654K$654K$654K$615K
Retained Earnings$693K$714K$716K$823K$945K
Accumulated OCI$64K$64K$64K$64K$64K
Total Stockholders Equity$1M$1M$1M$2M$2M
Total Liabilities & Equity$2M$2M$2M$2M$2M
— Key Metrics —
Total Debt$101K$0$44K$340K$287K
Net Debt-$421K-$1M-$313K-$77K-$378K
Total Investments$785K$0$816K$854K$558K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms